BIOMIMETIC THERAPEUTICS, INC.: 10-Q filed 2011-08-05

Name: BIOMIMETIC THERAPEUTICS, INC.: 10-Q filed 2011-08-05
Creator: BIOMIMETIC THERAPEUTICS, INC.

What BIOMIMETIC THERAPEUTICS, INC. reported in its quarterly report filed 2011-08-05 (fiscal Q2 2011): 29 published measures, 74 facts as tagged in accession 0001144204-11-044038.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-08-05
Fiscal period: fiscal Q2 2011
Accession: 0001144204-11-044038 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOMIMETIC THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-06-30	91,063,929	USD
At 2010-12-31	105,554,828	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-06-30	22,064,638	USD
At 2010-12-31	22,433,088	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-06-30	68,999,291	USD
At 2010-12-31	83,121,740	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-06-30	16,509,347	USD
At 2010-12-31	11,628,329	USD
At 2010-06-30	9,059,520	USD
At 2009-12-31	21,543,347	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-8,241,037	USD	91
2011-01-01 to 2011-06-30	-16,194,351	USD	181
2010-04-01 to 2010-06-30	-7,655,085	USD	91
2010-01-01 to 2010-06-30	-16,177,326	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-15,524,058	USD	181
2010-01-01 to 2010-06-30	-13,920,699	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	1,715,420	USD	181
2010-01-01 to 2010-06-30	258,598	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	439,281	USD	91
2011-01-01 to 2011-06-30	837,966	USD	181
2010-04-01 to 2010-06-30	374,564	USD	91
2010-01-01 to 2010-06-30	726,893	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	126,597	USD	181
2010-01-01 to 2010-06-30	283,869	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	20,278,479	USD	181
2010-01-01 to 2010-06-30	1,153,003	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-06-30	-143,651,722	USD
At 2010-12-31	-127,457,371	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2011-04-01 to 2011-06-30	USD	91
2011-01-01 to 2011-06-30	USD	181
2010-04-01 to 2010-06-30	USD	91
2010-01-01 to 2010-06-30	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-06-30	8,773,890	USD
At 2010-12-31	7,592,820	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	1,874,257	USD	181
2010-01-01 to 2010-06-30	1,891,729	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-8,265,969	USD	91
2011-01-01 to 2011-06-30	-16,259,377	USD	181
2010-04-01 to 2010-06-30	-7,683,575	USD	91
2010-01-01 to 2010-06-30	-16,208,115	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	73,603,496	USD
At 2010-12-31	80,702,054	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-06-30	7,203,853	USD
At 2010-12-31	7,219,489	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-06-30	1,461,518	USD
At 2010-12-31	1,670,830	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2011-06-30	54,081	USD
At 2010-12-31	8,050	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2011-06-30	3,559,512	USD
At 2010-12-31	2,258,193	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	3,763,403	USD	91
2011-01-01 to 2011-06-30	7,848,235	USD	181
2010-04-01 to 2010-06-30	3,934,333	USD	91
2010-01-01 to 2010-06-30	8,117,883	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	28,001,018	shares
At 2010-12-31	27,925,984	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-06-30	212,607,411	USD
At 2010-12-31	210,553,647	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2011-06-30	15,601	USD
At 2010-12-31	-2,462	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2011-06-30	2,261,465	USD
At 2010-12-31	1,867,937	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	4,653,058	USD	91
2011-01-01 to 2011-06-30	8,675,315	USD	181
2010-04-01 to 2010-06-30	3,252,066	USD	91
2010-01-01 to 2010-06-30	7,080,975	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	9,551	USD	91
2011-01-01 to 2011-06-30	17,609	USD	181
2010-04-01 to 2010-06-30	546,136	USD	91
2010-01-01 to 2010-06-30	1,092,258	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	6,736	USD	181
2010-01-01 to 2010-06-30	-319,306	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	1,301,319	USD	181
2010-01-01 to 2010-06-30	31,685	USD	181

Inspect the source

Entity: BIOMIMETIC THERAPEUTICS, INC. / CIK 0001138400
Captured: 2026-09-23 02:47 UTC
SEC response SHA-256: b32f827da9cf66218f73c4e43ab16d464f6edad21a31aaef0caecf1be4c9da25

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001138400.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))